8 Papers
2 Citations
Ping Zhao is an academic researcher from North China University of Science and Technology. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
The effects of metformin in the treatment of osteoarthritis: Current perspectives
TL;DR: It is concluded that metformin may be beneficial in the treatment of osteoarthritis by inhibiting inflammation, modulating autophagy, antagonizing oxidative stress, and reducing pain levels.
Heidihuangwan alleviates renal fibrosis in rats with 5/6 nephrectomy by inhibiting autophagy
Ying-Ying Li,Zengrui Tian,Guangchao Pan,Ping Zhao,D. Pan,Jun-qing Zhang,Li Ye,Fangfei Zhang,Xiang-dong Xu +8 more
TL;DR: Investigation of the mechanism of HeidihuangWan to improve renal fibrosis showed that HDHW inhibited autophagy by upregulating IGF-1 expression, promoting the binding of IGF- 1 to IGF-2R, and activating the PI3K/Akt/mTOR signaling pathway, thereby reducing renal Fibrosis and protecting renal function.
Therapeutic Effect and Mechanism of Acupuncture in Autoimmune Diseases.
Jing Wang,Fang Zhu,Wei-Ran Huang,Zheng-Yi Chen,Ping Zhao,Yanting Lei,Yumei Liu,Xijun Liu,Bo Sun,Hulun Li +9 more
TL;DR: In this review, the present knowledge regarding mechanisms of acupuncture in the treatment of AIDs has been summarized, and deeper insights will be provided in order to better understand how acupuncture may regulate immune responses during AIDs.
5
The comparison of the effects of local cooling and heating on apoptosis and pyroptosis of early-stage pressure ulcers in rats
TL;DR: It was suggested that the mitochondrial apoptotic pathway and pyroptosis were involved in the formation of early‐stage PUs, and local heating increased the PU injury in rats, while local cooling reduced the PU Injury in rats.
4
Clinical Efficacy Evaluation and Long-Term Prognosis of Glucagon-Like Peptide-1 Combined with Sodium Glucose Cotransporter-2 Inhibitor in Diabetes
Yan Pi,Ting Ting Du,Ping Zhao +2 more
TL;DR: The combination of glucagon-like peptide-1 agonist and sodium glucose cotransporter-2 inhibitor can improve diabetes in overweight or obesity patients with type 2 diabetes mellitus and effectively reduce blood glucose and body mass index.